PharmaVOICE, US: Cognizant’s SVP and Global Markets Leader, Life Sciences Named to the PharmaVOICE100
 |
PharmaVOICE has named Cognizant’s Bhaskar Sambasivan to the publication’s PharmaVOICE 100 ranking of the most influential and inspirational leaders from across the life-sciences industry. Excerpts:
“Wanting to ‘be remembered as a pioneer in the shift to digital in the life-sciences industry,’ Sambasivan is pushing the boundaries at Cognizant Life Sciences to become the most reliable, trusted, and flexible partner in the industry’s transformation journey. Seen as a go-to partner for customers to develop and implement their transformation initiatives across business and IT, the business has grown multi-fold and is consistently positioned at the top of the leadership rankings in the analyst reports across the value-chain of clinical, commercial, supply chain, and digital.
Under Sambasivan’s guidance, Cognizant partnered with TransCelerate BioPharma, to build a first-of-a-kind industry platform that will maximize technology-based collaboration, provide greater efficiency to clinical sites, and enable innovation in improving patient health. He has also expanded the company’s footprint beyond North America, growing the Company’s business in the United Kingdom, and enabled the acquisitions of Cadient, a human-focused design capability company, and marketRx, a domain-focused commercial operations and analytics capability company.
Believing strongly in ‘delivering success’ versus ‘successful delivery’, Sambasivan notes, ‘success is measured by ensuring the outcomes and results of clients have been met, and not by meeting our own goals’ and defines leadership by three traits: leading by example and adding value to the team and not by authority; being strategic and visionary; and having the ability to make timely and tough decisions.
The PharmaVOICE 100 celebrates the men and women throughout the life-sciences industry who provide inspiration to their peers, colleagues, and companies through innovative and motivational approaches to addressing the industry’s myriad challenges."
Click here or the document below to read more.
